The primary function of the corpus luteum (CL) is to synthesize and secrete progesterone to provide uterine quiescence for the establishment and maintenance of pregnancy. Any premature disruption in the function of the corpus luteum can result in a loss of pregnancy, irregular cyclicity, and a reduction in reproductive efficiency. The inhibition of steroid synthesis (functional regression), and the eventual disruption of cellular homeostasis (structural regression), is collectively described as luteolysis. More recently, cytokines have been implicated in an active role in luteolysis; yet the exact mechanisms by which they elicit their cytotoxic activity remains to be demonstrated. Recent evidence suggests that the signal for cell death, whether it be by TNFalpha, IFNgamma, FAS ligand or other stress-related stimuli, is mediated via the sphingomyelin pathway. Coincedently, these same factors have also been implicated in steroid inhibition and demise of the CL. Activation of the acid-sphingomyelinase by cytokines results in elevated ceramide levels. Subsequently, stress-induced ceramide is believed to preferentially signal through the cytoplasmic stress activated protein kinase (SAPK) a member of the mitogen activated protein kinase cascade (MAPKs). MAPKs are cytoplasmic enzymes responsible for translating the signal generated on the cell surface to the nucleus where they regulate transcription by phosphorylating transcription factors. We hypothesize that cytokines, as well as other cytotoxic stimuli, will initiate cell death via the sphingomyelin pathway and its second messenger ceramide in luteal cells. Furthermore, subsequent increases in ceramide will activate SAPKs which will ultimately phosphorylate specific transcription factors implicated in cellular demise and therefore play a role in the transition from functional inhibition of steroidogenesis to structural regression of the CL. To address this hypothesis we have proposed the following aims: (1) Determine if specific cytokines implicated in the regulation of the functional and structural aspects of luteal regression activate the sphingomyelin pathway. (2) Characterize the pleiotropic responses to cytokines (TNFalpha-INFgamma) as determined by the relative changes in ERKs and/or SAPKs/JNK and (3) the transcription factors c-fos and c-jun in luteal cells. (4) Determine whether or not steroid inhibition alone can activate the sphingomyelin pathway in cultured bovine luteal cells. (5) Determine the role of capase enzymes in ceramine activation. The experiments will utilize well defined primary cultures of bovine luteal cells and employ complimentary cellular and molecular techniques to address the aims. This project is expected to provide novel information on the cellular mechanisms involved in the process of luteolysis.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Research Project (R01)
Project #
1R01HD035934-01A1
Application #
2705109
Study Section
Biochemical Endocrinology Study Section (BCE)
Program Officer
Yoshinaga, Koji
Project Start
1998-12-08
Project End
2001-11-30
Budget Start
1998-12-08
Budget End
1999-11-30
Support Year
1
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Kansas
Department
Physiology
Type
Schools of Medicine
DUNS #
016060860
City
Kansas City
State
KS
Country
United States
Zip Code
66160
Cherry, Jessica Ann; Hou, Xiaoying; Rueda, Bo Ruben et al. (2008) Microvascular endothelial cells of the bovine corpus luteum: a comparative examination of the estrous cycle and pregnancy. J Reprod Dev 54:183-91
Henkes, Luiz E; Sullivan, Brian T; Lynch, Maureen P et al. (2008) Acid sphingomyelinase involvement in tumor necrosis factor alpha-regulated vascular and steroid disruption during luteolysis in vivo. Proc Natl Acad Sci U S A 105:7670-5
Hou, Xiaoying; Arvisais, Edward W; Jiang, Chao et al. (2008) Prostaglandin F2alpha stimulates the expression and secretion of transforming growth factor B1 via induction of the early growth response 1 gene (EGR1) in the bovine corpus luteum. Mol Endocrinol 22:403-14
Liptak, Amy R; Sullivan, Brian T; Henkes, Luiz E et al. (2005) Cooperative expression of monocyte chemoattractant protein 1 within the bovine corpus luteum: evidence of immune cell-endothelial cell interactions in a coculture system. Biol Reprod 72:1169-76
Davis, John S; Rueda, Bo R; Spanel-Borowski, Katherina (2003) Microvascular endothelial cells of the corpus luteum. Reprod Biol Endocrinol 1:89
Fanzo, Jessica C; Lynch, Maureen P; Phee, Hyewon et al. (2003) CD95 rapidly clusters in cells of diverse origins. Cancer Biol Ther 2:392-5
Henkes, Luiz E; Davis, John S; Rueda, Bo R (2003) Mutant mouse models and their contribution to our knowledge of corpus luteum development, function and regression. Reprod Biol Endocrinol 1:87
Carambula, Silvia F; Pru, James K; Lynch, Maureen P et al. (2003) Prostaglandin F2alpha- and FAS-activating antibody-induced regression of the corpus luteum involves caspase-8 and is defective in caspase-3 deficient mice. Reprod Biol Endocrinol 1:15
Pru, James K; Lynch, Maureen P; Davis, John S et al. (2003) Signaling mechanisms in tumor necrosis factor alpha-induced death of microvascular endothelial cells of the corpus luteum. Reprod Biol Endocrinol 1:17
Carambula, Silvia F; Matikainen, Tiina; Lynch, Maureen P et al. (2002) Caspase-3 is a pivotal mediator of apoptosis during regression of the ovarian corpus luteum. Endocrinology 143:1495-501

Showing the most recent 10 out of 15 publications